Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers (Q81747168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

Nick Andrews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

Elizabeth Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

Jo Southern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Moya Burrage

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

30 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

3829-3835

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

National study of infants hospitalized with pertussis in the acellular vaccine era.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Is pertussis being considered as a cause of persistent cough among adults?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Infant pertussis: who was the source?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Epidemiological, clinical, and laboratory aspects of pertussis in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Natural course of 500 consecutive cases of whooping cough: a general practice population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Severe and unrecognised: pertussis in UK infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Adult immunization with acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Development of an acellular pertussis vaccine and its administration as a booster in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Sero-epidemiology of Bordetella pertussis in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Whooping cough--a continuing problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Overview of recent clinical trials of acellular pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.02.030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893621%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference